Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study

Affiliations

• ¹ The Christ Hospital Heart and Vascular Institute and The Christ Hospital Research Institute, Cincinnati, OH (D.J.K.).
• ² AdventHealth Ocala (R.L.F.).
• ³ MediQuest Research Group, Ocala, FL (R.L.F.).
• ⁴ Amphia Ziekenhuis, Breda, the Netherlands (A.J.J.I.).
• ⁵ Shonan Kamakura General Hospital, Japan (S.S.).
• ⁶ Sapporo Higashi Tokushukai Hospital, Japan (S.S.).
• ⁷ OLVG Hospital, Amsterdam, the Netherlands (G.A.).
• ⁸ UNC Health System and UNC Rex Healthcare, Raleigh, NC (J.P.Z.).
• ⁹ New York Presbyterian Hospital and Weill Cornell Medicine (S.C.W.).
• ¹⁰ University Medical Center, Utrecht, the Netherlands (P.S.).
• ¹¹ OhioHealth Riverside Methodist Hospital, Columbus, OH (S.Y.).
• ¹² Washington University School of Medicine and Barnes Jewish Hospital, St. Louis MO (J.L.).
• ¹³ Cardiovascular Research Foundation, New York, NY (D.J.C.).
• ¹⁴ St. Francis Hospital, Roslyn, NY (D.J.C.).
• ¹⁵ Biostatistics Department, Boston University and Baim Institute for Clinical Research, Boston, MA (G.D.).
• ¹⁶ Beth Israel Deaconess Medical Center and Baim Institute for Clinical Research, Boston, MA (D.E.C.).
• ¹⁷ Duke Clinical Research Institute and Duke University Health System, Durham, NC (S.V.R.).